Fukuoka, Japan

Norikazu Nishino

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2002-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Norikazu Nishino: Innovator in Histone Methylation Research

Introduction

Norikazu Nishino is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of histone methylation. With a total of 6 patents to his name, his work has advanced our understanding of enzyme activity related to histone modifications.

Latest Patents

Nishino's latest patents include a method for assaying histone methylation enzyme activity. This innovative method provides a way to measure histone methyltransferase activity and screen for compounds that inhibit this activity. Additionally, he has developed a reagent kit for measuring histone methyltransferase activity and a kit for screening inhibitors. His patents also encompass a novel compound with histone deacetylase-inhibiting activity, which is a cyclic tetrapeptide derivative. This compound is designed to be used in pharmaceutical compositions, showcasing his commitment to translating research into practical applications.

Career Highlights

Throughout his career, Norikazu Nishino has worked with esteemed institutions such as the Kyushu Institute of Technology and RIKEN Corporation. His research has not only contributed to academic knowledge but has also paved the way for potential therapeutic advancements in the field of epigenetics.

Collaborations

Nishino has collaborated with notable colleagues, including Minoru Yoshida and Sueharu Horinouchi. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Norikazu Nishino's work in histone methylation research exemplifies the intersection of innovation and practical application in biochemistry. His contributions continue to influence the field and hold promise for future developments in therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…